Price $19.18 |
Market Cap
95.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
11.0
|
P/B
0.62
|
P/S
0.99
|
Dividend %
-
|
|
P/CF
38.5
|
P/FCF
9.5
|
Op. Cash Flow
14.5K
|
FCF
1.4
|
|
Op. Margin
15.00%
|
Net Margin
8.90%
|
ROE
5.70%
|
ROI
7.00%
|
|
ROA
4.40%
|
EPS Growth
-24.50%
|
Current Ratio
8.1
|
Debt/Equity
0.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $2.29 | - | - | 18.9M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $119.11 | - | - | 8.13B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.09 | - | - | 4.1M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $0.18 | - | - | 2.3M | Strong Buy |
| Inotiv Inc (NOTV) | $2.92 | - | - | 46.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
